This was the stock's sixth consecutive day of losses.
Did you analyze how IQVIA Holdings (IQV) fared in its international operations for the quarter ending December 2024? Given the widespread global presence of this clinical testing company, scrutinizing ...
Barclays analyst Luke Sergott maintained a Buy rating on Bruker (BRKR – Research Report) today and set a price target of $60.00. The company’s ...